Cellcom Israel, Ltd. (NYSE:CEL) has been given a consensus broker rating score of 5.00 (Strong Sell) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a strong sell rating.

Zacks has also assigned Cellcom Israel an industry rank of 190 out of 265 based on the ratings given to its competitors.

Separately, BidaskClub cut Cellcom Israel from a “sell” rating to a “strong sell” rating in a report on Saturday, August 26th.

Several institutional investors have recently made changes to their positions in the business. Sphera Funds Management LTD. acquired a new stake in shares of Cellcom Israel in the third quarter valued at approximately $14,301,000. Vanguard Group Inc. increased its holdings in shares of Cellcom Israel by 8.7% in the second quarter. Vanguard Group Inc. now owns 1,016,527 shares of the technology company’s stock valued at $9,800,000 after purchasing an additional 81,105 shares during the last quarter. Bank of America Corp DE increased its holdings in shares of Cellcom Israel by 153.2% in the first quarter. Bank of America Corp DE now owns 47,781 shares of the technology company’s stock valued at $492,000 after purchasing an additional 28,910 shares during the last quarter. Credit Suisse AG increased its holdings in shares of Cellcom Israel by 61.6% in the first quarter. Credit Suisse AG now owns 61,754 shares of the technology company’s stock valued at $635,000 after purchasing an additional 23,544 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Cellcom Israel by 4.1% in the second quarter. Dimensional Fund Advisors LP now owns 78,732 shares of the technology company’s stock valued at $759,000 after purchasing an additional 3,102 shares during the last quarter. 6.97% of the stock is owned by institutional investors and hedge funds.

Shares of Cellcom Israel (NYSE:CEL) traded down $0.04 during trading on Thursday, hitting $9.96. The company’s stock had a trading volume of 6,900 shares, compared to its average volume of 13,531. Cellcom Israel has a fifty-two week low of $7.74 and a fifty-two week high of $11.19. The firm has a market capitalization of $1,010.00, a PE ratio of 31.25 and a beta of 2.08. The company has a quick ratio of 1.41, a current ratio of 1.44 and a debt-to-equity ratio of 1.97.

TRADEMARK VIOLATION WARNING: “Zacks: Cellcom Israel, Ltd. (CEL) Receives Consensus Rating of “Strong Sell” from Brokerages” was first published by American Banking News and is the property of of American Banking News. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/12/07/zacks-cellcom-israel-ltd-cel-receives-consensus-rating-of-strong-sell-from-brokerages.html.

About Cellcom Israel

Cellcom Israel Ltd. is engaged in the provision of cellular telephone services. The Company offers fixed-line services. The Company operates in two segments: Cellular and Fixed-line. The cellular segment includes the cellular communications services, end user cellular equipment and supplemental services.

Get a free copy of the Zacks research report on Cellcom Israel (CEL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cellcom Israel Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellcom Israel Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.